FDA sends out another warning letter to CBD companies that promote that company products for medical uses and for treating diseases will be in violation of the FD&A Act.
FDA Warning Letters for Misbranding Cannabinoid Products as Dietary Supplement on the Rise – Bella Rose Labs
FDA issues warning letter to New York manufacturer for CBD claims that indicates its products are new drugs and do not qualify as dietary supplements
Federal District Court Orders New York Company to Stop Distributing Adulterated and Misbranded Dietary Supplements
FDA enforcement warning letters sent to manufacturers of CBD based dietary supplements due to non-permissible misbranding and adulteration claims
Regulatory compliance of cosmetics, diet, and CBD products including FDA misbranding and adulteration, FTC compliance, labeling requirements, and other legal issues.
FDA labeling is one of the most important regulatory requirements for dietary supplements in that it provides the consumer the necessary information on the product. Indeed, ensuring that all [...]
If you’re a dietary supplement manufacturer or distributor, know that FDA and FTC now encourage the public to report dietary supplement labeling violations.
Animal dietary supplement manufacturers and distributors can run afoul of FDA prohibitions against “drug” claims and receive an FDA warning letter, unless they understand how FDA regulates animal [...]
If you want to sell healthcare products online, the legal hurdles can be steep.
Substantiating claims matters whenever you bring a dietary supplement, cosmetic (or skin care product), or medical device to market - why?